Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of … – Mondaq News Alerts (registration)
|
Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of …
Mondaq News Alerts (registration) The European Medicines Agency (“EMEA”) made its biosimilar monoclonal antibody guidelines effective in December 20121. Less than a year later, in September 2013, it approved Europe’s first biosimilar antibody. The drug is Inflectra which is a … |
